AAAAAA

   
Results: 1-15 |
Results: 15
PHASE I-II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND 5-FLUOROURACIL(5-FU) IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
Authors: SCHRIJVERS D VANHERPEN C KERGER J JOOSENS E BRANDELY M VERMORKEN JB
Citation: D. Schrijvers et al., PHASE I-II STUDY WITH DOCETAXEL (D), CISPLATIN (C) AND 5-FLUOROURACIL(5-FU) IN PATIENTS WITH LOCALLY ADVANCED INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), Annals of oncology, 9, 1998, pp. 359-359
LU-103793 HAS ACTIVITY IN MELANOMA PATIENTS
Authors: SMYTH J SCHELLENS J KERGER J CALVERT H BRUNTSCH U HANAUSKE A
Citation: J. Smyth et al., LU-103793 HAS ACTIVITY IN MELANOMA PATIENTS, Annals of oncology, 9, 1998, pp. 557-557
INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC)
Authors: AWADA A DEVALERIOLA D GIL T KERGER J SELLESLAGS J MARIEN K VANVRECKEM A BRASSINNE C HENNEBERT P DEWJI R RIVA A PICCART M
Citation: A. Awada et al., INFLUENCE OF THE CYTOPROTECTIVE AGENT AMIFOSTINE ON TOXICITY AND PHARMACOKINETICS (PK) OF DOCETAXEL (D) IN METASTATIC BREAST-CANCER (MBC) -A FEASIBILITY STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC), Annals of oncology, 9, 1998, pp. 208-208
CLINICAL AND PHARMACOKINETIC PHASE-I STUDY OF THE COMBINATION OF DOCETAXEL (TXT), CISPLATIN (DDP) AND FLUOROURACIL (5-FU) IN PATIENTS WITH SOLID TUMORS
Authors: KERGER J DEVALERIOLA D BLEIBERG H BARTHOLOMEUS S BRASSINNE C WYTHOUCK H SOULAS F CAZENAVE I PICCART M
Citation: J. Kerger et al., CLINICAL AND PHARMACOKINETIC PHASE-I STUDY OF THE COMBINATION OF DOCETAXEL (TXT), CISPLATIN (DDP) AND FLUOROURACIL (5-FU) IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 364-364
DOCETAXEL (TAXOTERE) - AN ACTIVE AGENT IN METASTATIC UROTHELIAL CANCER - RESULTS OF A PHASE-II STUDY IN NON-CHEMOTHERAPY-PRETREATED PATIENTS
Authors: DEWIT R KRUIT WHJ STOTER G DEBOER M KERGER J VERWEIJ J
Citation: R. Dewit et al., DOCETAXEL (TAXOTERE) - AN ACTIVE AGENT IN METASTATIC UROTHELIAL CANCER - RESULTS OF A PHASE-II STUDY IN NON-CHEMOTHERAPY-PRETREATED PATIENTS, British Journal of Cancer, 78(10), 1998, pp. 1342-1345
DOCETAXEL (D) IN COMBINATION WITH AMIFOSTINE (A) IN METASTATIC BREAST-CANCER (MBC) - A FEASIBILITY AND PHARMACOKINETIC STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC)
Authors: AWADA A DEVALERIOLA D CORNEZ N KERGER J VANVRECKEM A BARTHOLOMEUS S SELLESLAGS J DEWJI R PICCART M
Citation: A. Awada et al., DOCETAXEL (D) IN COMBINATION WITH AMIFOSTINE (A) IN METASTATIC BREAST-CANCER (MBC) - A FEASIBILITY AND PHARMACOKINETIC STUDY OF THE EORTC-INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER (IDBBC), European journal of cancer, 33, 1997, pp. 710-710
MITOMYCIN-C AND VINBLASTINE IN COMBINATION WITH AMIFOSTINE IN METASTATIC BREAST-CANCER - A FEASIBILITY STUDY OF THE EORTC - INVESTIGATIONALDRUG BRANCH FOR BREAST-CANCER (IDBBC)
Authors: KUSENDA Z KERGER J AWADA A GEURS F VANVRECKEM A HABBOUBI N PICCART MJ
Citation: Z. Kusenda et al., MITOMYCIN-C AND VINBLASTINE IN COMBINATION WITH AMIFOSTINE IN METASTATIC BREAST-CANCER - A FEASIBILITY STUDY OF THE EORTC - INVESTIGATIONALDRUG BRANCH FOR BREAST-CANCER (IDBBC), Supportive care in cancer, 5(5), 1997, pp. 414-416
ZENIPLATIN IN ADVANCED MALIGNANT-MELANOMA AND RENAL-CANCER - PHASE-IISTUDIES WITH UNEXPECTED NEPHROTOXICITY
Authors: AAMDAL S BRUNTSCH U KERGER J VERWEIJ J HUININK WT WANDERS J RASTOGI R FRANKLIN HR KAYE SB
Citation: S. Aamdal et al., ZENIPLATIN IN ADVANCED MALIGNANT-MELANOMA AND RENAL-CANCER - PHASE-IISTUDIES WITH UNEXPECTED NEPHROTOXICITY, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 439-443
PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK
Authors: VERWEIJ J DEMULDER PHM DEGRAEFF A VERMORKEN JB WILDIERS J KERGER J SCHORNAGEL J COGNETTI F KIRKPATRICK A SAHMOUD T LEFEBVRE JL
Citation: J. Verweij et al., PHASE-II STUDY ON MITOXANTRONE IN ADENOID CYSTIC CARCINOMAS OF THE HEAD AND NECK, Annals of oncology, 7(8), 1996, pp. 867-869
INADVERTENT TRANSFER OF CHORIOCARCINOMA WITH RENAL-TRANSPLANTATION - CHARACTERISTICS OF THE DONOR-RECIPIENT PAIRS
Authors: DOUTRELEPONT JM MAT O ABRAMOWICZ D PICCART M KERGER J DEPAUW L VEREERTSTRAETEN P VANHERWEGHEM JL KINNAERT P
Citation: Jm. Doutrelepont et al., INADVERTENT TRANSFER OF CHORIOCARCINOMA WITH RENAL-TRANSPLANTATION - CHARACTERISTICS OF THE DONOR-RECIPIENT PAIRS, Transplantation proceedings, 27(2), 1995, pp. 1789-1790
DOCETAXEL (TAXOTERE) IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF THE EORTC EARLY CLINICAL-TRIALS GROUP
Authors: AAMDAL S WOLFF I KAPLAN S PARIDAENS R KERGER J SCHACHTER J WANDERS J FRANKLIN HR VERWEIJ J
Citation: S. Aamdal et al., DOCETAXEL (TAXOTERE) IN ADVANCED MALIGNANT-MELANOMA - A PHASE-II STUDY OF THE EORTC EARLY CLINICAL-TRIALS GROUP, European journal of cancer, 30A(8), 1994, pp. 1061-1064
PHASE-II STUDY WITH DOCETAXEL (TAXOTERE(R)) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT
Authors: VANHOESEL OGCM VERWEIJ J CATIMEL G CLAVEL M KERBRAT P VANOOSTEROM AT KERGER J TURSZ T VANGLABBEKE M VANPOTTELSBERGHE C LEBAIL N MOURIDSEN H
Citation: Ogcm. Vanhoesel et al., PHASE-II STUDY WITH DOCETAXEL (TAXOTERE(R)) IN ADVANCED SOFT-TISSUE SARCOMAS OF THE ADULT, Annals of oncology, 5(6), 1994, pp. 539-542
PHASE-I STUDY OF DOCETAXEL ADMINISTERED AS A 1-HOUR INTRAVENOUS-INFUSION ON A WEEKLY BASIS
Authors: TOMIAK E PICCART MJ KERGER J LIPS S AWADA A DEVALERIOLA D RAVOET C LOSSIGNOL D SCULIER JP AUZANNET V LEBAIL N BAYSSAS M KLASTERSKY J
Citation: E. Tomiak et al., PHASE-I STUDY OF DOCETAXEL ADMINISTERED AS A 1-HOUR INTRAVENOUS-INFUSION ON A WEEKLY BASIS, Journal of clinical oncology, 12(7), 1994, pp. 1458-1467
TUMOR STIMULATING EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6
Authors: RAVOET C DEGREVE J VANDEWOUDE K KERGER J SCULIER JP LACOR P STRYCKMANS P PICCART M
Citation: C. Ravoet et al., TUMOR STIMULATING EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-6, Lancet, 344(8936), 1994, pp. 1576-1577
POTENTIAL IN-VIVO GROWTH-STIMULATION OF HUMAN SOLID TUMORS BY RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6)
Authors: RAVOET C DEGREVE J STRYCKMANS P LACOR P KERGER J SCULIER JP VANDEWOUDE K LIPS S BLANK A ALEXIOU J PICCART M
Citation: C. Ravoet et al., POTENTIAL IN-VIVO GROWTH-STIMULATION OF HUMAN SOLID TUMORS BY RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6), Blood, 84(10), 1994, pp. 10000585-10000585
Risultati: 1-15 |